{"Schizophrenia": [0], "is": [1, 24, 204], "one": [2], "of": [3, 20, 50, 71, 108, 162, 275, 377, 504, 527, 539, 549], "the": [4, 160, 163, 191, 464, 537, 542], "most": [5, 503], "common,": [6], "burdensome,": [7], "and": [8, 36, 52, 57, 81, 95, 131, 154, 169, 214, 441, 546, 551, 553], "costly": [9], "psychiatric": [10], "disorders": [11], "in": [12, 103, 116, 139, 159, 167, 190, 198, 478, 488, 512, 522, 531], "adults": [13, 104], "worldwide.": [14], "Antipsychotic": [15], "drugs": [16, 529], "are": [17, 496, 506, 514], "its": [18], "treatment": [19, 119], "choice,": [21], "but": [22, 502], "there": [23], "controversy": [25], "about": [26], "which": [27], "agent": [28], "should": [29, 535], "be": [30], "used.": [31], "We": [32, 61, 98, 113, 147], "aimed": [33], "to": [34, 86, 253, 257, 260, 287, 291, 294, 307, 310, 313, 325, 328, 331, 349, 352, 355, 366, 369, 372, 386, 389, 392, 398, 411, 414, 418, 431, 434, 438, 452, 455, 459], "compare": [35], "rank": [37], "antipsychotics": [38, 229], "by": [39], "quantifying": [40], "information": [41], "from": [42, 83, 248, 282, 304, 322, 346, 363, 383, 407, 427, 448], "randomised": [43, 54, 100], "controlled": [44, 55, 101], "trials.We": [45], "did": [46, 467], "a": [47], "network": [48], "meta-analysis": [49], "placebo-controlled": [51, 484], "head-to-head": [53], "trials": [56, 102], "compared": [58, 270, 336, 397], "32": [59], "antipsychotics.": [60], "searched": [62], "Embase,": [63], "MEDLINE,": [64], "PsycINFO,": [65], "PubMed,": [66], "BIOSIS,": [67], "Cochrane": [68], "Central": [69], "Register": [70], "Controlled": [72], "Trials": [73, 78], "(CENTRAL),": [74], "WHO": [75], "International": [76], "Clinical": [77], "Registry": [79], "Platform,": [80], "ClinicalTrials.gov": [82], "database": [84], "inception": [85], "Jan": [87], "8,": [88], "2019.": [89], "Two": [90], "authors": [91], "independently": [92], "selected": [93], "studies": [94, 115, 164, 217], "extracted": [96, 149], "data.": [97], "included": [99, 215], "with": [105, 118, 143, 184, 206, 218, 243, 271, 337], "acute": [106], "symptoms": [107, 141, 232, 277, 300, 318], "schizophrenia": [109], "or": [110, 125, 181, 477, 493], "related": [111], "disorders.": [112], "excluded": [114], "patients": [117], "resistance,": [120], "first": [121], "episode,": [122], "predominant": [123], "negative": [124, 299], "depressive": [126, 317], "symptoms,": [127], "concomitant": [128], "medical": [129, 544], "illnesses,": [130], "relapse-prevention": [132], "studies.": [133], "Our": [134], "primary": [135, 465], "outcome": [136, 466], "was": [137, 193, 490], "change": [138, 470], "overall": [140, 231], "measured": [142], "standardised": [144, 176, 244], "rating": [145], "scales.": [146], "also": [148], "data": [150, 219], "for": [151, 220, 240, 255, 262, 273, 289, 296, 298, 316, 339, 358, 375, 400, 421, 442, 463, 473, 556], "eight": [152, 155], "efficacy": [153, 498], "safety": [156], "outcomes.": [157], "Differences": [158, 511], "findings": [161, 518], "were": [165, 175], "explored": [166], "metaregressions": [168], "sensitivity": [170, 479], "analyses.": [171], "Effect": [172, 224], "size": [173, 225], "measures": [174], "mean": [177, 179, 245, 268], "differences,": [178, 180], "risk": [182], "ratios": [183, 335], "95%": [185], "credible": [186], "intervals": [187], "(CrIs).": [188], "Confidence": [189], "evidence": [192, 489], "assessed": [194], "using": [195], "CINeMA": [196], "(Confidence": [197], "Network": [199], "Meta-Analysis).": [200], "The": [201, 486], "study": [202], "protocol": [203], "registered": [205], "PROSPERO,": [207], "number": [208], "CRD42014014919.We": [209], "identified": [210], "54": [211], "417": [212], "citations": [213], "402": [216], "53": [221], "463": [222], "participants.": [223], "estimates": [226], "suggested": [227], "all": [228], "reduced": [230], "more": [233, 515], "than": [234, 509], "placebo": [235, 272, 338, 399], "(although": [236], "not": [237, 468], "statistically": [238], "significant": [239], "six": [241], "drugs),": [242], "differences": [246, 269, 396, 499], "ranging": [247], "-0\u00b789": [249], "(95%": [250, 284], "CrI": [251, 285], "-1\u00b708": [252], "-0\u00b771)": [254], "clozapine": [256], "-0\u00b703": [258], "(-0\u00b759": [259], "0\u00b752)": [261], "levomepromazine": [263], "(40": [264], "815": [265], "participants).": [266], "Standardised": [267], "reduction": [274], "positive": [276], "(31": [278], "179": [279], "participants)": [280, 303, 321, 344, 362, 382, 405, 426, 447], "varied": [281], "-0\u00b769": [283], "-0\u00b786": [286], "-0\u00b752)": [288], "amisulpride": [290], "-0\u00b717": [292], "(-0\u00b731": [293], "-0\u00b704)": [295], "brexpiprazole,": [297], "(32": [301], "015": [302], "-0\u00b762": [305], "(-0\u00b784": [306], "-0\u00b739;": [308], "clozapine)": [309, 388, 433], "-0\u00b710": [311], "(-0\u00b745": [312], "0\u00b725;": [314], "flupentixol),": [315], "(19": [319], "683": [320], "-0\u00b790": [323], "(-1\u00b736": [324], "-0\u00b744;": [326], "sulpiride)": [327], "0\u00b704": [329], "(-0\u00b739": [330], "0\u00b747;": [332], "flupentixol).": [333], "Risk": [334], "all-cause": [340], "discontinuation": [341], "(42": [342], "672": [343], "ranged": [345, 406], "0\u00b752": [347], "(0\u00b712": [348], "0\u00b795;": [350], "clopenthixol)": [351], "1\u00b715": [353], "(0\u00b736": [354], "1\u00b747;": [356], "pimozide),": [357], "sedation": [359], "(30": [360], "770": [361], "0\u00b792": [364], "(0\u00b717": [365], "2\u00b703;": [367], "pimozide)": [368], "10\u00b720": [370], "(4\u00b772": [371], "29\u00b741;": [373], "zuclopenthixol),": [374], "use": [376], "antiparkinson": [378], "medication": [379], "(24": [380], "911": [381], "0\u00b746": [384], "(0\u00b719": [385], "0\u00b788;": [387], "6\u00b714": [390], "(4\u00b781": [391], "6\u00b755;": [393], "pimozide).": [394], "Mean": [395], "weight": [401], "gain": [402], "(28": [403], "317": [404], "-0\u00b716": [408], "kg": [409, 416], "(-0\u00b773": [410], "0\u00b740;": [412], "ziprasidone)": [413], "3\u00b721": [415], "(2\u00b710": [417], "4\u00b731;": [419], "zotepine),": [420], "prolactin": [422], "elevation": [423], "(21": [424], "569": [425], "-77\u00b705": [428], "ng/mL": [429, 436], "(-120\u00b723": [430], "-33\u00b754;": [432], "48\u00b751": [435], "(43\u00b752": [437], "53\u00b751;": [439], "paliperidone)": [440], "QTc": [443], "prolongation": [444], "(15": [445], "467": [446], "-2\u00b721": [449], "ms": [450, 457], "(-4\u00b754": [451], "0\u00b715;": [453], "lurasidone)": [454], "23\u00b790": [456], "(20\u00b756": [458], "27\u00b733;": [460], "sertindole).": [461], "Conclusions": [462], "substantially": [469], "after": [471], "adjusting": [472], "possible": [474], "effect": [475], "moderators": [476], "analyses": [480], "(eg,": [481], "when": [482], "excluding": [483], "studies).": [485], "confidence": [487], "often": [491], "low": [492], "very": [494], "low.There": [495], "some": [497], "between": [500], "antipsychotics,": [501], "them": [505], "gradual": [507], "rather": [508], "discrete.": [510], "side-effects": [513], "marked.": [516], "These": [517], "will": [519], "aid": [520], "clinicians": [521], "balancing": [523], "risks": [524], "versus": [525], "benefits": [526], "those": [528], "available": [530], "their": [532], "countries.": [533], "They": [534], "consider": [536], "importance": [538], "each": [540], "outcome,": [541], "patients'": [543], "problems,": [545], "preferences.German": [547], "Ministry": [548], "Education": [550], "Research": [552], "National": [554], "Institute": [555], "Health": [557], "Research.": [558]}